Product correctly added to cart.

discount label
1'-Epi gemcitabine, hydrochloride
View 3D

Biosynth logo

1'-Epi gemcitabine, hydrochloride

CAS: 122111-05-1

Ref. 3D-IE16542

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Wednesday 15 Jan 2025

Product Information

Name:
1'-Epi gemcitabine, hydrochloride
Synonyms:
  • 4-Amino-1-(2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone
  • hydrochloride
  • 1’-Epi Gemcitabine Hydrochloride
Description:

Gemcitabine hydrochloride is an analog of the natural nucleoside cytidine. It is a chemotherapeutic drug that is used in the treatment of pancreatic, lung and breast cancer. Gemcitabine hydrochloride is metabolized to its active form by deamination of cytosine residues in DNA. This conversion is catalyzed by the enzyme cytidine deaminase. Gemcitabine hydrochloride has been shown to be effective against metastatic pancreatic cancer and advanced-stage non-small cell lung cancer, as well as early-stage breast cancer. Gemcitabine hydrochloride has also been shown to be effective against certain types of lymphoma and leukemia.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
299.66 g/mol
Formula:
C9H12ClF2N3O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IE16542 1'-Epi gemcitabine, hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".